date,title,source
Oct-23-18,Myriad Announces Publication of Foresight Carrier Screen Clinical Utility Study in Genetics in Medicine,GlobeNewswire
Oct-24-18,"Myriad to Announce Fiscal First-Quarter 2019 Financial Results on November 6, 2018",GlobeNewswire
Oct-30-18,Myriad Genetics to Present at the Stephens New York Investment Conference,GlobeNewswire
Nov-05-18,Myriad Receives the Prestigious 2018 Utah Top Workplaces Award,GlobeNewswire
Nov-06-18,Myriad Genetics (MYGN) Beats Q1 Earnings Estimates,Zacks
Nov-06-18,Myriad: Fiscal 1Q Earnings Snapshot,Associated Press
Nov-06-18,Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results,GlobeNewswire
Nov-07-18,Edited Transcript of MYGN earnings conference call or presentation 6-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Here's Why Myriad Genetics Dropped as Much as 10.8% Today,Motley Fool
Nov-08-18,Is Myriad Genetics Incs (NASDAQ:MYGN) CEO Paid At A Competitive Rate?,Simply Wall St.
Nov-08-18,"Myriad Genetics (MYGN) Beats on Earnings in Q1, Revenues Lag",Zacks
Nov-12-18,Myriad to Present New Data from Its Industry-Leading Portfolio of Genetic Tests for Breast Cancer at the 2018 San Antonio Breast Cancer Symposium,GlobeNewswire
Nov-13-18,4 Quality Stocks to Counter Market Volatility,Zacks
Nov-16-18,This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019,Motley Fool
Nov-19-18,3 High-Growth Stocks That Are Just Getting Started,Motley Fool
Nov-19-18,Myriad Genetics announces $50 million accelerated share buyback,MarketWatch
Nov-19-18,Myriad Announces $50 Million Accelerated Share Repurchase Program,GlobeNewswire
Nov-27-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Dillard's, Biohaven Pharmaceutical Holding, HTG Molecular Diagnostics, Strongbridge Biopharma, Myriad Genetics, and Beazer Homes  New Research Emphasizes Economic Growth",GlobeNewswire
Dec-06-18,Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations,GlobeNewswire
Dec-10-18,Here's Why Myriad Genetics Lost 28.4% in November,Motley Fool
Dec-10-18,Myriad Genetics Announces Encouraging EndoPredict Test Data,Zacks
Dec-11-18,Here's Why You Should Buy Myriad Genetics (MYGN) Stock Now,Zacks
